Principal Financial Group Inc. cut its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 342,596 shares of the medical equipment provider’s stock after selling 8,428 shares during the quarter. Principal Financial Group Inc. owned about 0.37% of Varian Medical Systems worth $34,281,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Oregon Public Employees Retirement Fund increased its position in shares of Varian Medical Systems by 1.5% during the third quarter. Oregon Public Employees Retirement Fund now owns 35,815 shares of the medical equipment provider’s stock worth $3,584,000 after buying an additional 529 shares during the period. Pettee Investors Inc. acquired a new stake in shares of Varian Medical Systems during the third quarter worth $686,000. Wesbanco Bank Inc. increased its position in shares of Varian Medical Systems by 16.1% during the third quarter. Wesbanco Bank Inc. now owns 6,845 shares of the medical equipment provider’s stock worth $685,000 after buying an additional 950 shares during the period. American Century Companies Inc. increased its position in shares of Varian Medical Systems by 582.5% during the third quarter. American Century Companies Inc. now owns 137,303 shares of the medical equipment provider’s stock worth $13,739,000 after buying an additional 117,184 shares during the period. Finally, State of Tennessee Treasury Department increased its position in shares of Varian Medical Systems by 126.6% during the third quarter. State of Tennessee Treasury Department now owns 75,843 shares of the medical equipment provider’s stock worth $7,589,000 after buying an additional 42,370 shares during the period. Institutional investors own 99.15% of the company’s stock.

In other Varian Medical Systems news, insider Dow R. Wilson sold 15,059 shares of the firm’s stock in a transaction on Thursday, September 7th. The shares were sold at an average price of $105.41, for a total value of $1,587,369.19. Following the transaction, the insider now directly owns 81,835 shares of the company’s stock, valued at $8,626,227.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director R Andrew Eckert sold 5,651 shares of the firm’s stock in a transaction on Friday, October 6th. The shares were sold at an average price of $102.39, for a total transaction of $578,605.89. The disclosure for this sale can be found here. Insiders sold 42,761 shares of company stock worth $4,447,864 over the last ninety days. Insiders own 0.91% of the company’s stock.

Varian Medical Systems, Inc. (VAR) opened at $109.03 on Friday. Varian Medical Systems, Inc. has a 12 month low of $76.94 and a 12 month high of $109.71. The firm has a market cap of $10,010.00, a price-to-earnings ratio of 29.00, a price-to-earnings-growth ratio of 3.21 and a beta of 0.65. The company has a quick ratio of 1.13, a current ratio of 1.41 and a debt-to-equity ratio of 0.18.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The business had revenue of $739.00 million during the quarter, compared to the consensus estimate of $741.69 million. During the same period last year, the business posted $1.03 earnings per share. The firm’s quarterly revenue was down 1.1% on a year-over-year basis. equities research analysts anticipate that Varian Medical Systems, Inc. will post 4.26 EPS for the current fiscal year.

A number of research firms have commented on VAR. BidaskClub cut shares of Varian Medical Systems from a “hold” rating to a “sell” rating in a report on Thursday, August 3rd. Robert W. Baird restated a “hold” rating and issued a $99.00 price target on shares of Varian Medical Systems in a report on Monday, August 28th. BTIG Research cut shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a report on Thursday, September 7th. They noted that the move was a valuation call. Royal Bank Of Canada restated a “hold” rating and issued a $100.00 price target on shares of Varian Medical Systems in a report on Friday, September 1st. Finally, Citigroup Inc. raised their price target on shares of Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a report on Monday, October 30th. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. Varian Medical Systems presently has a consensus rating of “Hold” and an average target price of $97.83.

ILLEGAL ACTIVITY NOTICE: This news story was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this news story on another publication, it was illegally copied and reposted in violation of United States & international trademark and copyright laws. The legal version of this news story can be viewed at https://theolympiareport.com/2017/11/18/varian-medical-systems-inc-var-stake-decreased-by-principal-financial-group-inc.html.

Varian Medical Systems Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.